Streptomycin
Back to searchMolecule Structure
Scientific Name
Streptomycin
Description of the Drug
Streptomycin is an aminoglycoside antibiotic indicated to treat multi-drug resistant mycobacterium tuberculosis and various non-tuberculosis infections.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01082
http://www.drugbank.ca/drugs/DB01082
Brand Name(s)
Not Available
Company Owner(s)
John D Copanos And Co Inc, Pfizer Laboratories Div Pfizer Inc, Xgen Pharmaceuticals Djb Inc, Eli Lilly And Co
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Bacterial 70S ribosome | PROTEIN NUCLEIC-ACID COMPLEX | INHIBITOR | CHEMBL2363135 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL3276 | |
PharmGKB | PA451512 | |
Human Metabolome Database | HMDB0015214 | |
DrugBank | DB01082 | |
PubChem: Thomson Pharma | 14911392 | 14911393 |
PubChem | 19649 | |
NMRShiftDB | 60058699 | |
Nikkaji | J4.500D | |
PDBe | SRY | |
BindingDB | 50103513 | |
EPA CompTox Dashboard | DTXSID4023597 | |
DrugCentral | 2481 | |
Metabolights | MTBLC17076 | |
Brenda | 2358 | |
ChemicalBook | CB3462887 | |
Guide to Pharmacology | 10923 | |
rxnorm | STREPTOMYCIN | STREPTOMYCIN SULFATE |
KEGG Ligand | C00413 | |
ChEBI | 17076 | |
ZINC | ZINC000008214681 |